ClinicalTrials.Veeva

Menu

Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit (EB3REA)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Enterobacteriaceae Infections
Critically Ill
Antibiotic Resistant Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04528043
PSS2018/EB3REA-NOVY/YB

Details and patient eligibility

About

There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.

Enrollment

179 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adults critically ill patients admitted to the the participating ICUs during the study period
  • with colonization and/or infection with a third group enterobacteriacea
  • and with a lenght of stay > 24h

Exclusion criteria

  • minors patients
  • lenght of stay < 24h

Trial design

179 participants in 1 patient group

critically ill patients
Description:
critically ill patients admitted in one of the 5 ICUs of the university hospital of Nancy during the year 2016 with documented third group enterobacteriaceae infection and/or colonization with third group enterobacteriaceae

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems